Author Question: What should the nurse explain to a client with Addison disease as the reason for needing ... (Read 22 times)

EY67

  • Hero Member
  • *****
  • Posts: 531
What should the nurse explain to a client with Addison disease as the reason for needing mineralocorticoid replacement therapy?
 
  1. Mineralocorticoids will reduce excessive serum glucose levels.
  2. Mineralocorticoids will mimic the action of cortisol.
  3. Mineralocorticoids will mimic the action of aldosterone.
  4. Mineralocorticoids will reduce harmful bronzing of the skin.

Question 2

The nurse would question the administration of mineralocorticoid replacement therapy for which client?
 
  1. Client with a defect in the stimulation of aldosterone secretion
  2. Client with a defect in aldosterone sensitivity
  3. Client with a defect in the secretion of aldosterone
  4. Client with Conn syndrome



pratush dev

  • Sr. Member
  • ****
  • Posts: 321
Answer to Question 1

Correct Answer: 3
Rationale 1: This is not an indication for use of mineralocorticoids.
Rationale 2: Mineralocorticoids do not mimic the action of cortisol.
Rationale 3: Mineralocorticoids, in addition to glucocorticoids, are indicated for use in clients with adrenocortical insufficiency.
Rationale 4: Bronzing of the skin would not be affected by the use of mineralocorticoids, and is not harmful to clients with Addison disease.
Global Rationale: Mineralocorticoids, in addition to glucocorticoids, are indicated for use in clients with adrenocortical insufficiency. They do not mimic the action of cortisol or affect the bronzing of the skin. Serum glucose levels are not affected.

Answer to Question 2

Correct Answer: 4
Rationale 1: This client should receive mineralocorticoid replacement.
Rationale 2: This client should receive mineralocorticoid replacement.
Rationale 3: This client should receive mineralocorticoid replacement.
Rationale 4: A client with Conn syndrome already has oversecretion of aldosterone and does not require mineralocorticoid replacement therapy.
Global Rationale: A client with Conn syndrome already has oversecretion of aldosterone and does not require mineralocorticoid replacement therapy. Mineralocorticoid replacement is used to treat the other conditions.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

In the United States, congenital cytomegalovirus causes one child to become disabled almost every hour. CMV is the leading preventable viral cause of development disability in newborns. These disabilities include hearing or vision loss, and cerebral palsy.

Did you know?

In the United States, there is a birth every 8 seconds, according to the U.S. Census Bureau's Population Clock.

Did you know?

When Gabriel Fahrenheit invented the first mercury thermometer, he called "zero degrees" the lowest temperature he was able to attain with a mixture of ice and salt. For the upper point of his scale, he used 96°, which he measured as normal human body temperature (we know it to be 98.6° today because of more accurate thermometers).

Did you know?

Methicillin-resistant Staphylococcus aureus or MRSA was discovered in 1961 in the United Kingdom. It if often referred to as a superbug. MRSA infections cause more deaths in the United States every year than AIDS.

Methicilli ...

For a complete list of videos, visit our video library